Beetham Thomas W. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$217,045.17
Insider Sells Quantity
6
Insider Sells Sum
$3.86M

Insider Activity of Beetham Thomas W.

Biography of Beetham Thomas W.

No biography is available at this moment.

2024-09-27PurchaseViridian Therapeutics, Inc.
VRDN
Chief Operating Officer
5,000
0.0066%
$23.41$117,050-24.9%
2021-02-03SaleKiniksa Pharmaceuticals, Ltd.
KNSA
EVP & Chief Legal Officer
4,954
0.0076%
$22.09$109,434-36.09%
2020-07-01SaleKiniksa Pharmaceuticals, Ltd.
KNSA
EVP & Chief Legal Officer
59,178
0.0892%
$25.37$1.5M-30.75%
2020-06-10SaleKiniksa Pharmaceuticals, Ltd.
KNSA
EVP & Chief Legal Officer
27,504
0.0261%
$13.33$366,628-24.94%
2020-04-21SaleKiniksa Pharmaceuticals, Ltd.
KNSA
EVP & Chief Legal Officer
5,036
0.0059%
$13.82$69,613-5.23%
2020-04-20SaleKiniksa Pharmaceuticals, Ltd.
KNSA
EVP & Chief Legal Officer
94,846
0.1643%
$19.06$1.81M+2.13%
2020-02-14SaleKiniksa Pharmaceuticals, Ltd.
KNSA
EVP & Chief Legal Officer
118
0.0002%
$18.58$2,192+8.02%
2018-02-09PurchaseKiniksa Pharmaceuticals, Ltd.
KNSA
Chief Legal Officer
12,784
–
$7.82$99,995
Total: 8
*Some uncertain data for Preferred Stock share type transactions are shown in italics; for actual data please follow the link
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.